Previous article
Teenager With Unexplained Pain and Physical Injuries
Aug 2024
Next article
Tirzepatide (Zepbound) for the Treatment of Obesity
FPIN's Clinical Inquiries
From the Family Practice Inquiries Network

SBIRT for Alcohol Use in Adolescents

Katherine Bergs, PhD, LMFT
Adam Guck, PhD, ABPP
Jesse Kao, MD
Morgan Fields, MD
Andrew Maxwell, MD

American Family Physician. 2024;110(2):197-198.

Author disclosure: No relevant financial relationships.

KATHERINE BERGS, PhD, LMFT, is a psychologist and faculty member at JPS Family Medicine Residency Program, Fort Worth, Texas

ADAM GUCK, PhD, ABPP, is a psychologist and faculty member at JPS Family Medicine Residency Program, Fort Worth, Texas

JESSE KAO, MD, is a resident at JPS Family Medicine Residency Program, Fort Worth, Texas

MORGAN FIELDS, MD, is a resident at JPS Family Medicine Residency Program, Fort Worth, Texas

ANDREW MAXWELL, MD, is a resident at JPS Family Medicine Residency Program, Fort Worth, Texas

Address correspondence to Katherine Bergs, PhD, LMFT, at kbergs@jpshealth.org.

Author disclosure: No relevant financial relationships.

  1. 1.McDanal R, Parisi D, Opara I, et al. Effects of brief interventions on internalizing symptoms and substance use in youth: a systematic review. Clin Child Fam Psychol Rev. 2022;25(2):339-355.
  2. 2.D’Amico EJ, Parast L, Osilla KC, et al. Understanding which teenagers benefit most from a brief primary care substance use intervention. Pediatrics. 2019;144(2):e20183014.
  3. 3.Sterling S, Kline-Simon AH, Weisner C, et al. Pediatrician and behavioral clinician–delivered screening, brief intervention and referral to treatment: substance use and depression outcomes. J Adolesc Health. 2018;62(4):390-396.
  4. 4.Sterling S, Parthasarathy S, Jones A, et al. Young adult substance use and healthcare use associated with screening, brief intervention and referral to treatment in pediatric primary care. J Adolesc Health. 2022;71(4 S):S15-S23.
  5. 5.Levy SJL, Williams JF; Committee on Substance Use and Prevention. Substance use screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e20161211.
  6. 6.Krist AH, Davidson KW, Mangione CM, et al. Screening for unhealthy drug use: U.S. Preventive Services Task Force recommendation statement. JAMA. 2020;323(22):2301-2309.

Clinical Inquiries provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (https://www.cebm.net).

The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to https://www.fpin.org or email questions@fpin.org.

Copyright © Family Physicians Inquiries Network. Used with permission.

This series is coordinated by John E. Delzell Jr., MD, MSPH, associate medical editor.

A collection of FPIN’s Clinical Inquiries published in AFP is available at https://www.aafp.org/afp/fpin.

Previous article
Teenager With Unexplained Pain and Physical Injuries
Aug 2024
Next article
Tirzepatide (Zepbound) for the Treatment of Obesity

Current issue

May 2026

May 2026

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.